Deseblok 5 mg FC tablets
PDF Leaflet Revision Date: 12 April 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Relief of allergic rhinitis and chronic idiopathic urticaria symptoms.
Dosage (summary)
1 tablet (5 mg) once daily for adults and adolescents u2265 12 years.
Onset of Action / Duration
Onset: 1-2 hours, Duration: 24 hours
Special Populations
- Severe renal insufficiency
- Children under 12 years
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding.
Key Drug Interactions
- Ketoconazole
- Erythromycin
- Fluoxetine
Contraindications
- Hypersensitivity to desloratadine or excipients
Common side effects
- Headache
- Dizziness
- Somnolence
- Dry mouth
Counselling Points
- Avoid alcohol
- May cause dizziness, caution with driving
Serious warnings
- Caution in patients with a history of seizures
Important Disclaimer
The Deseblok 5 mg FC tablets professional information leaflet below is the property of Smart Pharmaceuticals and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
